ENVALITH
株式会社中京医薬品 logo

CHUKYOIYAKUHIN CO.,LTD.

4558Standard MarketPharmaceuticals

株式会社中京医薬品 logo
CHUKYOIYAKUHIN CO.,LTD.4558
Reference Indicators

Market Cap

23¥100M

P/E (Forecast)

24.7x

P/B

0.8x

Dividend Yield (Forecast)

2.53%

ROE

3.3%

EV/EBITDA

11.5x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
5,3565,6926,1246,3066,569
Cost of Sales
1,6951,9962,4212,661
Gross Profit
3,6603,6953,7033,6453,715
SG&A Expenses
3,5963,6363,5743,5393,588
Operating Income
6459128106127
Non-operating Income
2424232026
Non-operating Expenses
543814
Ordinary Income
8479147117139
Extraordinary Income
11264
Extraordinary Losses
121271725
Pre-tax Income
947720125118
Income Taxes
6162478035
Net Income
3314-274583
EBITDA
149150225203209
Gross Margin
68.3%64.9%60.5%57.8%56.6%
Operating Margin
1.2%1.0%2.1%1.7%1.9%
ROA
0.6%0.3%-0.5%0.9%1.6%
ROE
1.3%0.6%-1.1%1.8%3.3%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
家庭医薬品等販売事業000.0%
売水事業部門759759.9%
その他100.0%